Abstract:OBJECTIVE:To investigate the role of cyclooxygenase-2(COX-2)and its products in plaque vulnerability at the different stages of atherogenesis.DATA SOURCES:An online search of Medline was undertaken to identify articles about COX-2 and plaque vulnerability in atherosclerosis published in English between January 1998 and June 2005 by using the Keywords of "cyclooxygenase,coronary atherosclerosis,plaque vulnerability".Meanwhile,the Chinese articles related to COX-2 and atherosclerotic plaque vulnerability were searched in the Chinese journals full-text database with computer by using the keywords of "cyclooxygenase,atherosclerosis,plaque vulnerability".STUDY SELECTION:After the preliminary selection,the literatures included treatment group and control group were selected,and the obvious non-randomized clinical trials and basic studies were deleted,then the full-texts of the rest literatures were scanned.Inclusion criteria:①randomized control study;②experimental or clinical studies including parallel control group.Exclusion criteria:Repetitive study or review.DATA EXTRACTION:A total of 110 articles of randomized and non-randomized studies about COX-2 and plaque vulnerability in atherosclerosis were collected,and 17 met the inclusion criteria.Of the 93 deleted ones,44 were non-randomized or repetitive studies,and 49 were reviews.DATA SYNTHESIS:①COX expressed at the different stages of atherosclerotic lesion formation.COX-2 could enhance the adhesion of circulating monocytes to activated endothelial cells in early atherogenesis,which might induce the rapid expression of COX-2mRNA in turn.Within atherosclerotic lesions,COX-2 was largely expressed by macrophages in advanced atherogenesis.However,macrophage COX-2 might down-regulate in mature foam cells.②COX-2/microsomal PGE protein greatly expressed within the shoulder region of atherosclerotic plaque,where plaque rupture usually occurred.PGE2 could induce the expression of plaque matrix metalloproteinases,and thus degrading the composition of plaque.③Further studies should be conducted to investigate whether selective COX-2 inhibitor might retard atherogenesis and decrease the occurrence of cardiovascular events or accelerate atherogenesis and increase the occurrence of cardiovascular events. CONCLUSION:COX and its products play an important role for plaque vulnerability at the different stages of atherogenesis.COX-2 is closely related to atherosclerosis,and may provide a novel potential target for the prevention and treatment of atherosclerosis.

[COX-2 and mPGES-1 expression in carotid atherosclerotic plaques].

Cyclooxygenase and atherosclerotic plaque vulnerability

Expression of Mac-2 Binding Protein in Human Carotid Atheroma is Associated with Plaque Instability and Clinical Manifestations.

Expression of nitric oxide synthase and heme oxygenase in carotid atherosclerotic plaque

Cyclooxygenase-2 and Prostaglandin E2 are Associated with Middle Cerebral Artery Occlusion and Hemorrhage in Patients with Moyamoya Disease.

Cyclooxygenase-2 expression, prostacyclin production and endothelial protection of high-density lipoprotein.

Expression of NF-κB, CD68 and CD105 in Carotid Atherosclerotic Plaque.

Characterisation of IL-22 and Interferon-Gamma-inducible Chemokines in Human Carotid Plaque

Study on expression of platelet membrane glycoproteins in cerebral infarction with carotid atherosclerosis

[Expression and Significance of Inflammatory Factors and Bone Formation Mediators in Carotid Atherosclerotic Plaque].

Cyclooxygenase-2 in human pathological disease

Observations on the morphology and inflammatory reaction of carotid atherosclerotic plaques and its clinical manifestations

Expression of COX-2 and its role in rat arterial thrombosis

Expression of P53, P16 and Cyclooxygenase-2 in Esophageal Cancer with Tissue Microarray

COX-2 Mediates PM2.5-induced Apoptosis and Inflammation in Vascular Endothelial Cells

Microsomal prostaglandin E2 synthase-1 and its inhibitors: Molecular mechanisms and therapeutic significance

The expression of renin-angiotensin system components in human carotid plaque

Expression of cox-2 in human colorectal carcinoma and its clinical significance

[The Expression of Chemokine-Like Factor 1 in Human Atherosclerotic Plaques].

Bioinformatics analysis reveals the landscape of immune cell infiltration and immune-related pathways participating in the progression of carotid atherosclerotic plaques

Identification of Potential Key Genes Involved in the Carotid Atherosclerosis